| Project/Area Number |
16H06611
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Hirosaki University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
KASHIWAKURA Ikuo
EBINA Satoko
HIROUCHI Tokuhisa
|
|---|
| Project Period (FY) |
2016-08-26 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | ヒト造血幹細胞 / 電離放射線 / 遺伝子発現解析 / 白血病 / 臍帯血 / 遺伝子発現 / 造血幹細胞 / 放射線 / ヒト造血幹/前駆細胞 / サイトカイン |
|---|
| Outline of Final Research Achievements |
To clarify the nature of genes and related signaling pathways that contribute to the radiation-related leukemia on human hematopoietic stem cells (HSCs), we analyzed the gene expression profiles and its related signaling pathways detected in HSCs irradiated with 2 Gy X-rays before culture with or without an optimal combination of hematopoietic cytokines. In the absence of hematopoietic cytokines, expression control pathways related to carcinogenesis such as RB/E2F, Est and p53, and carcinogenesis such as C/EBP were enhanced after X-rays irradiation. On the other hand, culture with cytokine combination (recombinant human thrombopoietin plus interleukin-3 plus stem cell factor) that exerts radiation protection effect showed a specific enhancement of CD44 signaling pathways.It is suggested the importance of CD44 signaling pathway to the radiation response of human HSCs.
|
